Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia.
A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia. Thyroid. 2019 08; 29(8):1158-1167.
View in:
PubMed
subject areas
Animals
Autophagy
Disease Models, Animal
Fatty Acids
Fatty Liver
Glucose-6-Phosphatase
Glycogen
Glycogen Storage Disease Type I
Liver
Mice
Mice, Knockout
Mitochondria, Liver
Organelle Biogenesis
Organophosphonates
Oxidation-Reduction
Thyroid Hormone Receptors beta
Triglycerides
authors with profiles
Samuel Refetoff